cGAS activation converges with intracellular acidification to promote STING aggregation and pyroptosis in tumor models

Xiao Li, Yuan-li Ai, Xiaoyi Mi, Liang Han, Xiang Zhi, Liu-zheng Wu, Qi-Tao Chen, Tong Gou, Chao Chen, Bo Zhou, Wenbin Hong, Luming Yao, Junjie Chen, Xianming Deng, Fu-Nan Li, Qiao Wu, Hang‐zi ChenJournal of Clinical Investigation 2025 · DOI

TL;DR

Researchers have discovered a novel mechanism where a compound called DHN triggers programmed cell death (pyroptosis) in cancer cells by activating a noncanonical cGAS/STING pathway. This pathway involves mitochondrial damage, DNA release, and intracellular acidification, ultimately leading to the formation of STING aggregates in the ER that recruit and activate caspases to induce cell death, offering a promising new avenue for cancer therapy.

What Problem Does This Paper Address?

The cGAS/STING pathway is well-known for its role in initiating anti-tumor immunity by sensing foreign or self-DNA and triggering inflammatory responses. However, its direct role in causing tumor cell death, specifically pyroptosis, has been unclear. Pyroptosis is a highly inflammatory form of cell death that can be therapeutically beneficial by releasing tumor antigens and stimulating an immune response. This paper addresses the gap in understanding how the cGAS/STING pathway can directly induce pyroptosis, particularly in cancer cells, and identifies a novel compound and mechanism that achieves this.

Methods

The study employed a multi-faceted approach:

  • Compound Screening: A library of compounds was screened to identify those inducing lytic cell death, leading to the discovery of DHN.
  • Cellular Assays: Standard assays were used to measure cell death (LDH release), pyroptotic morphology, and protein cleavage (Western blotting for GSDME, caspase-8, etc.).
  • Molecular Biology Techniques: Gene knockdown (siRNA/shRNA) and knockout (CRISPR) were used to investigate the roles of specific proteins like GSDME, caspase-8, CypD, cGAS, and STING.
  • Mitochondrial Assays: Mitochondrial membrane potential, ROS production, and mitochondrial DNA release were assessed.
  • Protein-Protein Interaction Studies: Surface plasmon resonance (SPR) and co-immunoprecipitation were used to confirm direct binding and interactions between DHN and CypD, and between STING and other proteins.
  • Confocal and Electron Microscopy: These techniques were used to visualize cellular structures, protein localization (STING in ER), and mitochondrial morphology.
  • Biochemical Assays: Phos-tag gels were used to detect protein phosphorylation, and in vitro kinase assays were performed.
  • In Vivo Studies: Xenograft mouse models were used to evaluate the anti-tumor efficacy of DHN and analyze immune cell infiltration and activation within tumors.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • DHN as a Pyroptosis Inducer: DHN is identified as a novel compound that specifically induces pyroptosis in melanoma cells, a type of cell death that is often resistant to apoptosis.
  • Mitochondrial Targeting: DHN directly targets cyclophilin D (CypD) in mitochondria, leading to the opening of the mitochondrial permeability transition pore (mPTP).
  • mtDNA Release and cGAS Activation: The opening of mPTP by DHN causes the release of mitochondrial DNA (mtDNA) into the cytoplasm, which then activates the cGAS enzyme.
  • Intracellular Acidification as a Co-factor: DHN also induces intracellular acidification, which is crucial for activating PERK (protein kinase R-like endoplasmic reticulum kinase).
  • Noncanonical STING Activation: Unlike the canonical cGAS/STING pathway that leads to IFN production, this pathway involves PERK-mediated phosphorylation of STING. This phosphorylation traps STING in the ER and promotes its polymerization into aggregates.
  • ER-STING Aggregates as a Platform: These ER-localized STING aggregates act as a scaffold to recruit FADD and caspase-8, leading to caspase-8 activation and subsequent cleavage of GSDME, the executioner of pyroptosis.
  • Acidic Environment for Caspase-8: The study highlights that caspase-8 can directly cleave GSDME in an acidic environment, suggesting a novel regulatory mechanism for cell death.
  • Dual Requirement for Pyroptosis: The findings suggest that both cGAS activation (via mtDNA release) and intracellular acidification are necessary for this noncanonical STING-mediated pyroptosis.
  • In Vivo Efficacy and Immune Modulation: DHN demonstrates significant anti-tumor effects in mouse models, leading to tumor regression and enhanced activation of cytotoxic immune cells within the tumor microenvironment.

Key Results

  • DHN treatment of melanoma cells led to characteristic pyroptotic morphology, significant LDH release, and cleavage of GSDME.
  • Knockdown of GSDME or inhibition of caspase-8 significantly attenuated DHN-induced pyroptosis.
  • DHN directly binds to mitochondrial protein CypD, and its inhibition or knockdown blocked DHN-induced pyroptosis.
  • DHN treatment resulted in mtDNA release into the cytoplasm, which was dependent on CypD and mPTP opening.
  • DHN induced the formation of STING puncta specifically within the ER, which was dependent on cGAS and mPTP opening.
  • Intracellular acidification, induced by DHN, was essential for PERK activation and subsequent STING phosphorylation and polymerization.
  • PERK-mediated STING phosphorylation at Ser345 and Ser358 was critical for STING polymerization and ER-STING aggregate formation.
  • DHN significantly suppressed tumor growth in xenograft mouse models and enhanced the activation of CD8+ T cells and NK cells.

Limitations and Future Work

  • Mechanism of DHN-induced Acidification: While DHN induces intracellular acidification, the precise molecular mechanism behind this effect is not fully elucidated, though the authors suggest DHN's weak acidic nature might play a role. Further investigation into how DHN alters cellular pH is warranted.
  • Specificity of DHN's mPTP Targeting: While DHN targets CypD, the exact mechanism by which it promotes mPTP opening, beyond direct binding, could be further explored. The study notes that complete abolition of mtDNA release was not achieved by CypD or ANT1 inhibition, suggesting other factors might be involved.
  • Noncanonical cGAS/STING Activation: The study demonstrates that DHN-induced pyroptosis bypasses the canonical TBK1/IRF3 activation pathway. Understanding the precise downstream effectors and signaling cascades of this noncanonical STING activation remains an area for future research.
  • Clinical Translation: While DHN shows promising anti-tumor effects and minimal toxicity in mice, further preclinical and clinical studies are needed to assess its therapeutic potential in humans.
  • Sex as a Biological Variable: The study did not consider sex as a biological variable, and it is unknown if the findings are relevant for female mice.

Summary updated

Abstract

The cyclic GMP-AMP synthase (cGAS)/stimulator of IFN genes (STING) pathway is intimately associated with antitumoral immunity; however, the direct involvement of this pathway in tumor cell demise remains elusive. Here, we identified a compound, dodecyl 6-hydroxy-2-naphthoate (DHN), that induces pyroptosis in melanoma cells by activating noncanonical cGAS/STING signaling. DHN targets mitochondrial protein cyclophilin D (CypD) to induce the release of mitochondrial DNA, leading to cGAS activation and cyclic GMP-AMP (cGAMP) generation. Meanwhile, DHN-caused intracellular acidification induces protein kinase R-like endoplasmic reticulum kinase (PERK) activation, which promotes STING phosphorylation and polymerization in the presence of cGAMP, thereby facilitating the aggregation of STING in the ER, which serves as a platform to recruit Fas-associated via death domain (FADD) and caspase-8, leading to caspase-8 activation and subsequent gasdermin E cleavage, which ultimately results in pyroptosis of tumor cells and tumor regression in mouse models. The occurrence of this noncanonical cGAS/STING pathway-associated pyroptosis is also observed when both cGAS is activated and intracellular pH declines. Collectively, our findings reveal a pathway that links noncanonical cGAS/STING signaling to gasdermin E-mediated pyroptosis, thereby offering valuable insights for tumor therapy.
BibTeX
@article{li2025cgas,
  author = {Xiao Li and Yuan-li Ai and Xiaoyi Mi and Liang Han and Xiang Zhi and Liu-zheng Wu and Qi-Tao Chen and Tong Gou and Chao Chen and Bo Zhou and Wenbin Hong and Luming Yao and Junjie Chen and Xianming Deng and Fu-Nan Li and Qiao Wu and Hang‐zi Chen},
  title = {{cGAS activation converges with intracellular acidification to promote STING aggregation and pyroptosis in tumor models}},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci188872},
}

Loading related content...

Figure